Indications and Purposes
| 1 Indications And Usage Cometriq Is Indicated For The Treatment Of Patients With Progressive, Metastatic Medullary Thyroid Cancer (Mtc). Cometriq Is A Kinase Inhibitor Indicated For The Treatment Of Patients With Progressive, Metastatic Medullary Thyroid Cancer (Mtc). ( 1 ) |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Cabozantinib |
|
ZINC70466416 |